DCBLD1 gene expression was investigated in paired tumor tissue and normal adjacent tissue in the NSCLC (n = 108), invasive breast carcinoma (n = 111), colorectal adenocarcinoma (n = 32) and prostate adenocarcinoma (n = 52) TCGA cohorts (Fig. 3). Here, DCBLD1 is linked to prostate adenocarcinoma.